green
Positive treatment
4.3 score
Treatment trajectory · 2004 → 2026 · click a year to view as-of
2004
2015
2026
Top citers, strongest first. 4 distinct citers.
How cited ↗
examined
Cited "but see"
Edward Jerome Harbison v. Ricky Bell, Warden
(4×)
also: Cited "see"
But see Thompson v. Bell, 373 F.3d 688, 691 (6th Cir.2004) (allowing record on appeal to be supplemented under “our equitable power”), cert, granted on other grounds, — U.S.-, 125 S.Ct. 823 , 160 L.Ed.2d 609 (2005).
discussed
Cited "see"
Frank Howard v. Barbara Bouchard, Warden
(2×)
See Thompson v. Bell, 373 F.3d 688, 690 (6th Cir.2004) (stating that the Sixth Circuit does not allow consideration of materials under Appellate Rule 10(e) that have not been considered by the district court), cert. granted on other grounds, — U.S. -, 125 S.Ct. 823 , 160 L.Ed.2d 609 (2005).
cited
Cited "see"
William H. Smith, Petitioner-Appellee/cross-Appellant v. Carl S. Anderson, Warden, Respondent-Appellant/cross-Appellee
See Gonzalez v. Crosby, - U.S. -, 125 S.Ct. 961 , 160 L.Ed.2d 896 (2005), and Bell v. Thompson, - U.S. -, 125 S.Ct 823 , 160 L.Ed.2d 609 (2005).
discussed
Cited "see"
Nancy J. Roquet and Coretta Robinson v. Arthur Andersen LLP
(2×)
See Arthur Andersen LLP v. United States, cert. granted, — U.S. -, 125 S.Ct. 823 , 160 L.Ed.2d 609 (2005.) Even though Andersen made a last-ditch effort to persuade DOJ to change its mind, it knew that it was in serious trouble.
Retrieving the full opinion text from the archive…
Merck KGaA
v.
Integra Lifesciences I, Ltd., Et Al.
v.
Integra Lifesciences I, Ltd., Et Al.
03-1237.
Supreme Court of the United States.
Jan 7, 2005.
O'Connor, Breyer.
Published
C. A. Fed. Cir. Motion of Eli Lilly and Company for leave to file a brief as amicus curiae granted. Certiorari granted.
Justice O’Connor and Justice Breyer took no part[*1042] in the consideration or decision of this motion and this petition.